Trial intelligence / Profile preview

Leukocyte-poor PRP versus saline for knee osteoarthritis

jRCTb032190218Phase 2Completed

Start
Nov 2018
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms). Primary endpoint: Improvement rate of WOMAC score. Started Nov 2018; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on jRCTb032190218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTb032190218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call